Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -35.11M
March 31, 2026 -51.87M
December 31, 2025 -69.99M
September 30, 2025 -67.33M
June 30, 2025 -45.71M
March 31, 2025 -24.69M
December 31, 2024 -24.93M
September 30, 2024 -11.72M
June 30, 2024 -16.92M
March 31, 2024 -30.67M
Date Value
December 31, 2023 60.67M
September 30, 2023 162.80M
June 30, 2023 268.05M
March 31, 2023 436.54M
December 31, 2022 518.89M
September 30, 2022 478.85M
June 30, 2022 479.49M
March 31, 2022 478.28M
December 31, 2021 353.72M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Repligen Corp. 110.15M
Bio-Techne Corp. 263.22M
BioLife Solutions, Inc. 7.987M
MindWalk Holdings Corp. -9.062M
MaxCyte, Inc. -23.79M